Clinical trial
Modulation of Plasmacytoid Dendritic Cell Function in Multiple Sclerosis
NCT00468182 is registered in ClinicalTrials.gov with Rutgers, The State University of New Jersey as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Modulation of Plasmacytoid Dendritic Cell Function in Multiple Sclerosis
- Lead sponsor
- Rutgers, The State University of New Jersey
- Phase
- Observational
- Overall status
- Completed
- Start date
- April 30, 2007
- Completion date
- December 31, 2011
- Enrollment
- 24 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.